Search research articles
Contact Us
Filters
Showing results (271-280 of 421) with videos related to
Page
of 43
Sort By:
Antimicrobial Agents and Chemotherapy
|
April 24, 2004
Variety of beta-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United States
Keith S Kaye, Howard S Gold, Mitchell J Schwaber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 9, 2017
Electronically Available Comorbidities Should Be Used in Surgical Site Infection Risk Adjustment
Sarah S Jackson, Surbhi Leekha, Laurence S Magder, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2020
Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections
Keith S Kaye, Helen W Boucher, Michelle L Brown, et al.
Infection Control and Hospital Epidemiology
|
March 8, 2014
Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities
Ashish Bhargava, Kayoko Hayakawa, Ethan Silverman, et al.
American Journal of Infection Control
|
May 20, 2014
Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysis
Christopher Bogan, Keith S Kaye, Teena Chopra, et al.
Infection Control and Hospital Epidemiology
|
July 1, 2010
Observer bias in hand hygiene compliance reporting
Sorabh Dhar, Ryan Tansek, Elizabeth A Toftey, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
August 3, 2025
Corrigendum to "A quasi-experimental study of a bundled diagnostic stewardship intervention for ventilator-associated pneumonia" [Clin Microbiol Infect 30 (2024) 499-506]
Owen R Albin, Jonathan P Troost, Louis Saravolatz, et al.
Antibiotics (Basel, Switzerland)
|
August 6, 2021
In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
Jacinda C Abdul-Mutakabbir, Juwon Yim, Logan Nguyen, et al.
Infection Control and Hospital Epidemiology
|
July 5, 2012
Extended-spectrum β-lactamase producers reported as susceptible to piperacillin-tazobactam, cefepime, and cefuroxime in the era of lowered breakpoints and no confirmatory tests
Dror Marchaim, Bharath Sunkara, Paul R Lephart, et al.
Annals of Clinical Microbiology and Antimicrobials
|
June 5, 2015
Simple bedside score to optimize the time and the decision to initiate appropriate therapy for carbapenem-resistant Enterobacteriaceae
Violet Leibman, Emily T Martin, Ruthy Tal-Jasper, et al.
Page
of 43
Search research articles
Search
Showing results (271-280 of 421) with videos related to
Sort By:
Page
of 43
Antimicrobial Agents and Chemotherapy
|
April 24, 2004
Variety of beta-lactamases produced by amoxicillin-clavulanate-resistant Escherichia coli isolated in the northeastern United States
Keith S Kaye, Howard S Gold, Mitchell J Schwaber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 9, 2017
Electronically Available Comorbidities Should Be Used in Surgical Site Infection Risk Adjustment
Sarah S Jackson, Surbhi Leekha, Laurence S Magder, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2020
Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections
Keith S Kaye, Helen W Boucher, Michelle L Brown, et al.
Infection Control and Hospital Epidemiology
|
March 8, 2014
Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities
Ashish Bhargava, Kayoko Hayakawa, Ethan Silverman, et al.
American Journal of Infection Control
|
May 20, 2014
Outcomes of carbapenem-resistant Enterobacteriaceae isolation: matched analysis
Christopher Bogan, Keith S Kaye, Teena Chopra, et al.
Infection Control and Hospital Epidemiology
|
July 1, 2010
Observer bias in hand hygiene compliance reporting
Sorabh Dhar, Ryan Tansek, Elizabeth A Toftey, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
August 3, 2025
Corrigendum to "A quasi-experimental study of a bundled diagnostic stewardship intervention for ventilator-associated pneumonia" [Clin Microbiol Infect 30 (2024) 499-506]
Owen R Albin, Jonathan P Troost, Louis Saravolatz, et al.
Antibiotics (Basel, Switzerland)
|
August 6, 2021
In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
Jacinda C Abdul-Mutakabbir, Juwon Yim, Logan Nguyen, et al.
Infection Control and Hospital Epidemiology
|
July 5, 2012
Extended-spectrum β-lactamase producers reported as susceptible to piperacillin-tazobactam, cefepime, and cefuroxime in the era of lowered breakpoints and no confirmatory tests
Dror Marchaim, Bharath Sunkara, Paul R Lephart, et al.
Annals of Clinical Microbiology and Antimicrobials
|
June 5, 2015
Simple bedside score to optimize the time and the decision to initiate appropriate therapy for carbapenem-resistant Enterobacteriaceae
Violet Leibman, Emily T Martin, Ruthy Tal-Jasper, et al.
Page
of 43